Cynosure Group’s Transcat TRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,146
Closed -$786K 391
2025
Q2
$786K Sell
9,146
-28,347
-76% -$2.32M 0.09% 120
2025
Q1
$2.79M Buy
37,493
+32,007
+583% +$2.68M 0.38% 35
2024
Q4
$580K Sell
5,486
-174
-3% -$19.3K 0.09% 119
2024
Q3
$684K Buy
5,660
+2,576
+84% +$320K 0.1% 129
2024
Q2
$369K Buy
3,084
+198
+7% +$23.4K 0.06% 294
2024
Q1
$322K Buy
+2,886
New +$306K 0.06% 234

Other funds holding TRNS

Cynosure Group's TRNS Position: Q3 2025 in Review

Cynosure Group sold out of Transcat (TRNS) in Q3 2025, closing a stake of 9,146 shares — an estimated $786K sold.

Cynosure Group first reported a position in TRNS in Q1 2024 and held it in 6 quarters. The position peaked at $2.79M in Q1 2025. 154 funds tracked by Wall St. Rank hold TRNS as of Q3 2025.

  • Cynosure Group reported no remaining Transcat position as of Q3 2025 after selling out during the quarter.
  • Cynosure Group sold 9,146 Transcat shares in Q3 2025, an estimated $786K.
  • Cynosure Group first reported a position in Transcat in Q1 2024 and held it in 6 quarters.
  • Cynosure Group's Transcat position peaked at $2.79M in Q1 2025.
  • 154 funds tracked by Wall St. Rank held Transcat as of Q3 2025.

Based on Cynosure Group's 13F filing for Q3 2025, filed 22 Oct 2025.